Skip to main content

Strata Critical Medical, Inc.

For the period ended Dec 31, 2025. Filed Mar 3, 2026.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Mar 3, 2026

SRTA$6.02-0.5%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Power of Attorney (included on signature page)

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

STRATA CRITICAL MEDICAL, INC.
By:/s/ Melissa M. Tomkiel
Melissa M. Tomkiel
Co-Chief Executive Officer (Principal Executive Officer)
By:/s/ William A. Heyburn
William A. Heyburn
Co-Chief Executive Officer and Chief Financial Officer(Principal Executive & Financial Officer)

POWER OF ATTORNEY

Each person whose signature appears below constitutes and appoints each of Melissa M. Tomkiel and William A. Heyburn, acting alone or together with another attorney-in-fact, as his or her true and lawful attorney-in-fact and agent, with full power of substitution and resubstitution, for such person and in his or her name, place and stead, in any and all capacities, to sign any or all further amendments to this Annual Report on Form 10-K, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agent, or his or her substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

Pursuant to the requirements of the Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

SignatureTitleDate
/s/ Melissa M. TomkielCo-Chief Executive Officer and DirectorMarch 3, 2026
Melissa M. Tomkiel(Principal Executive Officer)
/s/ William A. HeyburnCo-Chief Executive Officer, Chief Financial Officer and DirectorMarch 3, 2026
William A. Heyburn(Principal Executive & Financial Officer)
/s/ Amir M. CohenChief Accounting OfficerMarch 3, 2026
Amir M. Cohen(Principal Accounting Officer)
/s/ Robert S. WiesenthalChairman of the BoardMarch 3, 2026
Robert S. Wiesenthal
/s/ Eric AffeldtDirectorMarch 3, 2026
Eric Affeldt
/s/ William CookDirectorMarch 3, 2026
William Cook
/s/ Andrew LauckDirectorMarch 3, 2026
Andrew Lauck
/s/ Reginald LoveDirectorMarch 3, 2026
Reginald Love
/s/ Susan LyneDirectorMarch 3, 2026
Susan Lyne
/s/ Edward PhilipDirectorMarch 3, 2026
Edward Philip
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.